|
Q3 2021
Filed on Nov 09, 2021
|
26
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
40
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
433
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
Onconova Therapeutics Inc
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
Mer Telemanagement Solutions
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
587
|
N/A
|
|
Maxim Integrated Prods Inc
|
Q3 2021
Filed on Nov 09, 2021
|
172
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
1,060
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
57
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
Ivy High Inc Opportunities F
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
Inotek Pharmaceuticals Corp
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
$0.13 - $2.36
$0 - $0
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
85,471
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
0
|
N/A
|
|